Previous 10 | Next 10 |
2023-03-07 14:00:39 ET The following slide deck was published by Heron Therapeutics, Inc. in conjunction with this event. For further details see: Heron Therapeutics (HRTX) presents at 2023 Cowen Conference - Slideshow
Heron Therapeutics Announces U.S. Commercial Launch of APONVIE™ for the Management of Postoperative Nausea and Vomiting in Adults PR Newswire - APONVIE, the first and only intravenous (IV) formulation of a substance P/neurokinin-1 (NK 1 ) receptor antagonist ind...
Heron Therapeutics Announces Presentation at 43rd Annual Cowen Healthcare Conference PR Newswire SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...
Penny stocks, also known as micro-cap stocks, are low-priced stocks that trade for less than $5 per share. Despite their low prices, these stocks can be a great way to make money in the stock market. However, they are also high-risk investments that can easily lead to significant lossesToto be su...
Heron Therapeutics ( NASDAQ: HRTX ) shares rose ~10% on Wednesday morning after announcing a cooperation agreement with two of its shareholders, Rubric Capital Management LP and Velan Capital Investment Management LP. Per the terms, Heron ( HRTX ) has agreed to add Craig Colla...
Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital PR Newswire Appoints Three New Independent Directors SAN DIEGO , Feb. 22, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (NASDAQ: HRTX) ("Heron" or the "Company"), a...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...
The shares of Heron Therapeutics ( NASDAQ: HRTX ) added ~14% in the morning hours Monday after the New York-based hedge fund Rubric Capital Management reported 9.9% ownership in the biotech, representing approximately 11.8M shares. San Diego, California-based Heron ( HRTX ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...
News, Short Squeeze, Breakout and More Instantly...
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 30, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company...
Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System PR Newswire SAN DIEGO , July 15, 2024 /PRNewswire/ -- Heron Therapeutics, Inc....
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire -The U.S. Food and Drug Administration ("FDA") assigned a Prescription Drug User Fee Act ("PDUFA") goal date of September 23, 2024 ...